238 related articles for article (PubMed ID: 29938473)
41. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
[TBL] [Abstract][Full Text] [Related]
42. Differences in behavioral outcomes between first-year and second-year participants in a community-based colorectal cancer education intervention.
Huang JY; Shi L
Asian Pac J Cancer Prev; 2011; 12(12):3323-9. PubMed ID: 22471474
[TBL] [Abstract][Full Text] [Related]
43. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
44. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
45. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.
Wilschut JA; Hol L; Dekker E; Jansen JB; Van Leerdam ME; Lansdorp-Vogelaar I; Kuipers EJ; Habbema JD; Van Ballegooijen M
Gastroenterology; 2011 Nov; 141(5):1648-55.e1. PubMed ID: 21784045
[TBL] [Abstract][Full Text] [Related]
47. Colorectal cancer screening and surveillance: a survey among Thai general surgeons.
Lohsiriwat V; Lohsiriwat D; Thavichaigarn P;
Asian Pac J Cancer Prev; 2009; 10(3):467-70. PubMed ID: 19640193
[TBL] [Abstract][Full Text] [Related]
48. The value of colonoscopic colorectal cancer screening of adults aged 50 to 64.
Fitch K; Pyenson B; Blumen H; Weisman T; Small A
Am J Manag Care; 2015 Jul; 21(7):e430-8. PubMed ID: 26295271
[TBL] [Abstract][Full Text] [Related]
49. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
50. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
Quintero E; Castells A; Bujanda L; Cubiella J; Salas D; Lanas Á; Andreu M; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Laredo E; Hernández V; Iglesias F; Cid E; Zubizarreta R; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; Polo-Tomás M; Bessa X; Ferrer-Armengou O; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; de la Vega-Prieto M; Reyes-Melian JM; Cacho G; Díaz-Tasende J; Herreros-de-Tejada A; Poves C; Santander C; González-Navarro A;
N Engl J Med; 2012 Feb; 366(8):697-706. PubMed ID: 22356323
[TBL] [Abstract][Full Text] [Related]
51. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
[TBL] [Abstract][Full Text] [Related]
52. Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.
Kingsley J; Karanth S; Revere FL; Agrawal D
PLoS One; 2016; 11(12):e0167452. PubMed ID: 27936028
[TBL] [Abstract][Full Text] [Related]
53. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
54. Fecal occult blood testing when colonoscopy capacity is limited.
Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
Allameh Z; Davari M; Emami MH
Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
[TBL] [Abstract][Full Text] [Related]
56. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese.
Wong MC; Tsoi KK; Ng SS; Lou VW; Choi SY; Ling KW; Chan FK; Griffiths SM; Sung JJ
Aliment Pharmacol Ther; 2010 Jul; 32(1):74-82. PubMed ID: 20345501
[TBL] [Abstract][Full Text] [Related]
57. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
58. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
59. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
60. Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea.
Bui NC; Cho HN; Lee YY; Suh M; Park B; Jun JK; Kim Y; Choi KS
Cancer Res Treat; 2018 Apr; 50(2):416-427. PubMed ID: 28494531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]